Relationship among CT-based abdominal adipose tissue areas and pancreatic ductal adenocarcinoma in male

Figures & data

Figure 1. TAT was measured by drawing a contour around the skin, VAT was measured by drawing around the visceral fat by identifying the innermost part of the abdominal wall muscles and anterior aspect of the vertebral column by manually. The SAT area was calculated by subtracting the VAT area from the TAT area.

Table 1. Data of the patient and control groups.

Parameters	PDAC Group	Control Group	p Value
	Mean±SD (min-max)	Mean±SD (min-max)
TAT area (cm^2)	310.24 ± 134.70 (113.2-744.49)	240.04 ± 82.21 (38.66-460.93)	0.002
VAT area (cm^2)	181.61 ± 83.85 (57.93-411.15)	144.87 ± 59.48 (12.98-351.83)	0.01
SAT area (cm^2)	128.62 ± 68.35 (47.65-393.42)	95.16 ± 35.10 (24.52-172.51)	0.003
VAT/TAT ratio	0.58 ± 0.10 (0.36-0.74)	0.59 ± 0.09 (0.33-0.76)	0.60
VAT/SAT ratio	1.55 ± 0.63 (0.57-2.99)	1.59 ± 0.62 (0.50-3.22)	0.73
SAT/TAT ratio	0.41 ± 0.10 (0.25-0.63)	0.40 ± 0.09 (0.23-0.66)	0.60

PDAC: Pancreatic ductal adenocarcinoma; VAT: visceral adipose tissue; SAT: subcutaneous adipose tissue; TAT: total adipose tissue; SD: standard deviation; min: minimum; max: maximum.

The level of statistical significance was considered as p < 0.05 in the study. Bold values are <0.05 and statistically significant.